T7 RNA Polymerase

OEM by QIAGEN offers bulk manufacturing of T7 RNA Polymerase in custom formulations.

S_1143_6_OEM_Generic_Product
Let’s talk custom
Need this product modified? Contact us to get started with tailored OEM solutions.
T7 RNA Polymerase (50,000 U)

Cat. No. / ID:  P7180L

50,000 U (evaulation pack) of T7 RNA Polymerase (50,000 U/ml) and 10X T7 RNA Polymerase Buffer.
The T7 RNA Polymerase (50,000 U) is intended for molecular biology applications. This product is not intended for the diagnosis, prevention, or treatment of a disease.
Let’s talk custom
Need this product modified? Contact us to get started with tailored OEM solutions.

Features

  • DNA-dependent RNA polymerase
  • High specificity for the T7 promotor
  • Catalyzes the Mg2+ dependent synthesis of RNA from rNTPs

Product Details

T7 RNA Polymerase provides 5ʹ→ 3ʹ RNA synthesis of RNA from a DNA template.

The enzyme is supplied in 50 mM Tris-HCl, 100 mM NaCl, 1 mM DTT, 0.1 mM EDTA, 50% glycerol and <0.1% Triton X-100; pH 7.9 at 25°C.

10X T7 RNA Polymerase Buffer (B7180) contains the following: 400 mM Tris-HCl, 60 mM MgCl2, 100 mM DTT and 20 mM spermidine; pH 7.9 at 25°C.

Performance

T7 RNA Polymerase is a DNA-dependent RNA polymerase having high specificity for the T7 promoter. After promoter initiation, it catalyzes the Mg2+ dependent synthesis of RNA from rNTPs.

Polymerase properties

  • Storage temperature: –25°C to –15°C
Test Units tested Specification
SDS purity >99%
Specific activity 312,500 U/mg
Single-stranded exonuclease 500 U <1.0% released
Double-stranded exonuclease 500 U <1.0% released
Double-stranded endonuclease 500 U No conversion
E. coli DNA contamination 500 U <10 copies
RNAse comtamination 500 U No detectable non-specific RNAse

Principle

Source of recombinant enzyme protein
The protein is produced by a strain ofE. coli that expresses the recombinant T7 RNA Polymerase gene.

Unit definition: One unit is defined as the amount of enzyme that will incorporate 1 nmol of ATP into acid-precipitable material in 1 hour at 37°C.

Molecular weight: 98,855 Daltons

Procedure

Quality control analysis

Unit activity was measured using a twofold serial dilution method. Dilutions of enzyme were made in 50% glycerol containing T7 RNA Polymerase storage solution and added to 50 µl reactions containing a T7 promoter-containing plasmid DNA, 1X T7 RNA Polymerase Buffer, 3H-ATP and 400 µM each ATP, GTP, CTP and UTP. Reactions were incubated 10 minutes at 37°C, placed on ice, and analyzed using the method of Sambrook and Russell (Molecular Cloning, v3, 2001, pp. A8.25-A8.26)

Protein concentration is determined by OD280 absorbance.

Physical purity is evaluated by SDS-PAGE of concentrated and diluted enzyme solutions followed by silver-stain detection. Purity is assessed by comparing the aggregate mass of contaminant bands in the concentrated sample to the mass of the band corresponding to the protein of interest in the diluted sample.

Single-stranded exonuclease is determined in a 50 µl reaction containing a radiolabeled single-stranded DNA substrate and 10 µl of enzyme solution incubated for 4 hours at 37°C.

Double-stranded exonuclease activity is determined in a 50 µl reaction containing a radiolabeled double-stranded DNA substrate and 10 µl of enzyme solution incubated for 4 hours at 37°C.

Double-stranded endonuclease activity is determined in a 50 µl reaction containing 0.5 µg of plasmid DNA and 10 µl of enzyme solution incubated for 4 hours at 37°C.

E. coli contamination is evaluated using 5 µl replicate samples of enzyme solution that are denatured and screened in a TaqMan qPCR assay for the presence of contaminating E. coli genomic DNA using oligonucleotide primers corresponding to the 16S rRNA locus.

Non-specific RNAse contamination is assessed using the RNAse Alert kit, (Integrated DNA Technologies), following the manufacturer’s guidelines.

Applications

This OEM by QIAGEN product is available for bulk purchase for the following commercial assay applications.

  • RNA synthesis from DNA template
  • RNA probe preparation
  • Applications in mRNA therapeutics